rs11622977

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001355436.2(SPTB):​c.6269+13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,613,462 control chromosomes in the GnomAD database, including 12,992 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2927 hom., cov: 33)
Exomes 𝑓: 0.11 ( 10065 hom. )

Consequence

SPTB
NM_001355436.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.62

Publications

5 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 14-64767290-G-A is Benign according to our data. Variant chr14-64767290-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257134.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.6269+13C>T intron_variant Intron 31 of 35 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.6269+13C>T intron_variant Intron 31 of 35 NM_001355436.2 ENSP00000495909.1 P11277-2

Frequencies

GnomAD3 genomes
AF:
0.165
AC:
25018
AN:
152034
Hom.:
2921
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.335
Gnomad AMI
AF:
0.0932
Gnomad AMR
AF:
0.100
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.00692
Gnomad SAS
AF:
0.0643
Gnomad FIN
AF:
0.0787
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.113
Gnomad OTH
AF:
0.139
GnomAD2 exomes
AF:
0.104
AC:
26102
AN:
251210
AF XY:
0.0997
show subpopulations
Gnomad AFR exome
AF:
0.339
Gnomad AMR exome
AF:
0.0647
Gnomad ASJ exome
AF:
0.0929
Gnomad EAS exome
AF:
0.00913
Gnomad FIN exome
AF:
0.0825
Gnomad NFE exome
AF:
0.112
Gnomad OTH exome
AF:
0.0999
GnomAD4 exome
AF:
0.108
AC:
157941
AN:
1461310
Hom.:
10065
Cov.:
33
AF XY:
0.106
AC XY:
77279
AN XY:
727006
show subpopulations
African (AFR)
AF:
0.342
AC:
11447
AN:
33470
American (AMR)
AF:
0.0698
AC:
3122
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0985
AC:
2575
AN:
26132
East Asian (EAS)
AF:
0.00557
AC:
221
AN:
39700
South Asian (SAS)
AF:
0.0687
AC:
5922
AN:
86252
European-Finnish (FIN)
AF:
0.0854
AC:
4532
AN:
53060
Middle Eastern (MID)
AF:
0.0902
AC:
520
AN:
5768
European-Non Finnish (NFE)
AF:
0.111
AC:
122918
AN:
1111826
Other (OTH)
AF:
0.111
AC:
6684
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
7791
15581
23372
31162
38953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4442
8884
13326
17768
22210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.165
AC:
25053
AN:
152152
Hom.:
2927
Cov.:
33
AF XY:
0.160
AC XY:
11924
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.335
AC:
13907
AN:
41492
American (AMR)
AF:
0.0998
AC:
1525
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
357
AN:
3468
East Asian (EAS)
AF:
0.00675
AC:
35
AN:
5188
South Asian (SAS)
AF:
0.0637
AC:
307
AN:
4820
European-Finnish (FIN)
AF:
0.0787
AC:
835
AN:
10608
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.113
AC:
7674
AN:
67980
Other (OTH)
AF:
0.138
AC:
291
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1016
2031
3047
4062
5078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.120
Hom.:
1178
Bravo
AF:
0.172
Asia WGS
AF:
0.0680
AC:
239
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 28, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.16
DANN
Benign
0.32
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11622977; hg19: chr14-65234008; API